Pomerantz LLP announced investigations into potential securities fraud and unlawful business practices at Stitch Fix, JinkoSolar, and America's Car-Mart. Stitch Fix's stock fell 21.63% following disappointing Q4 2026 earnings with declining active clients and net losses.

Pomerantz LLP announced investigations into securities fraud claims against SELLAS Life Sciences, JinkoSolar, and Stitch Fix. The investigation into SELLAS focuses on delayed release of phase 3 clinical trial results for Galinpepimut-S, which triggered an 13.15% stock price decline on August 28, 2026.

Pomerantz LLP announced investigations into potential securities fraud at Rent the Runway following the company's September 11, 2026 earnings report, which revealed a 3.8% year-over-year decline in active subscribers, disappointing Q3 guidance, and a dilutive capital raise. The stock fell 13.12% on the news. Similar investigations were initiated for JinkoSolar and Stitch Fix.

Pomerantz LLP announced investigations into potential securities fraud at Abeona Therapeutics following disclosure that only 4 of 5 ZEVASKYN treatments were recognized for revenue due to one batch lacking minimum sheet requirements. The stock fell 14.95% to $6.35 on August 13, 2026. Similar investigations were initiated for JinkoSolar and Stitch Fix.

Stitch Fix reported a quarterly loss of $0.01 per share, beating consensus estimates of $0.06 loss by 83.33%, with revenues of $324.42 million slightly missing expectations. However, the stock has declined 43.1% year-to-date versus the S&P 500's 13.4% gain. The company holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.

Vera Bradley reported quarterly earnings of $0.11 per share, significantly beating the consensus estimate of a loss of $0.08 per share, representing a 237.50% earnings surprise. The company also exceeded revenue expectations with $71.65 million, up from $70.86 million year-over-year. However, the stock received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market. The company's industry, Retail - Apparel and Shoes, ranks in the top 33% of Zacks industries.

Zumiez reported a quarterly loss of $0.17 per share, worse than the consensus estimate of $0.14, and missed revenue expectations with $208.96 million versus the estimate. The company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revisions. Zumiez shares have declined 32.6% year-to-date, significantly underperforming the S&P 500's 11.6% gain.

Torrid Holdings reported a quarterly loss of $0.04 per share, missing the consensus estimate of $0.03 loss, representing a -33.33% earnings surprise. Revenue of $231.73 million also missed expectations by 2.07%. The stock has gained 132% year-to-date but holds a Zacks Rank #3 (Hold) rating. Stitch Fix is expected to report a quarterly loss of $0.06 per share with revenues of $324.97 million.

Stitch Fix stock surged 16.67% after delivering better-than-expected Q3 fiscal 2026 results. Revenue rose 4.7% YoY to $340M, net revenue per active client climbed 6.6% to $578, and the company narrowed net losses to $1.5M. With improved cash generation and a debt-free balance sheet of $229M, Stitch Fix is conducting stock buybacks and projecting full-year revenue of $1.35B with positive free cash flow.

Stitch Fix, a fashion technology company using AI-powered styling, is struggling with declining active clients and challenging retail conditions. Despite management's efforts to adapt, the stock remains volatile and potentially risky for investors.

U.S. stocks traded lower midday, with the S&P 500 dropping 1%. Accenture reported strong Q4 earnings, beating analyst estimates, while several other companies experienced significant stock price movements.

Multiple consumer discretionary stocks experienced significant price movements, with some companies seeing notable gains while others faced substantial declines during Thursday's trading session.